Status:

ENROLLING_BY_INVITATION

Non-ischaemic Heart Preservation Versus Standard Cold Storage in Human Heart Transplantation

Lead Sponsor:

Region Skane

Collaborating Sponsors:

Lund University

Skane University Hospital

Conditions:

Transplant; Failure, Heart

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The overall aim of this study is to compare a new state-of-the-art ex-vivo organ preservation method with standard ischemic cold static storage of donor hearts in adult cardiac transplantation. Stand...

Detailed Description

SURVEY OF THE FIELD Ischemia and reperfusion (I/R) - elicited tissue injury contributes to morbidity and mortality. In organ transplantation, it is a major challenge. The imbalance in metabolic supply...

Eligibility Criteria

Inclusion

  • Inclusion Criteria recipient:
  • Age ≥18 years
  • Signed informed consent form
  • Listed for heart transplantation
  • Exclusion Criteria recipient:
  • Previous solid organ transplantation
  • Grown-up congenital heart disease (GUCH)
  • Kidney failure eGFR\<40, calculated by CDK-EPI Creatinine, or ultrafiltration or dialysis or rapidly deteriorating kidney function due to a diagnosed renal disease
  • Coagulopathy due to known hepatic disease or heparin induced thrombocytopenia
  • Ongoing septicemia defined as positive blood culture (including with a durable VAD)
  • Incompatible blood group
  • Not able to understand the information provided during the informed consent procedure
  • Patients under pre-transplant desensitization protocol
  • Short term mechanical support pre-transplant (ECMO)
  • Patient diagnosed with Systemic Lupus Erythematous, sarcoidosis or amyloidosis
  • Combined organ transplantation candidates
  • Patient already consented for another transplant related intervention study
  • Inclusion criteria donor:
  • Age ≤70 years
  • Accepted as heart donor by the transplant team (research consent from the donor if required in country)
  • Exclusion criteria donor:
  • Previous sternotomy
  • DCD hearts

Exclusion

    Key Trial Info

    Start Date :

    July 1 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2026

    Estimated Enrollment :

    66 Patients enrolled

    Trial Details

    Trial ID

    NCT04066127

    Start Date

    July 1 2020

    End Date

    December 31 2026

    Last Update

    May 8 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Skane University Hospital

    Lund, Skåne County, Sweden, 22185